10-Q: Flora Growth Corp. Reports First Quarter 2024 Results Amidst Restructuring Efforts

Flora Growth Corp. reported a net loss of $3.4 million for the first quarter of 2024, as the company continues to navigate challenges in the cannabis market and implement cost-cutting measures.

Summary

• Flora Growth Corp. reported a net loss of $3.4 million for the first quarter of 2024, compared to a $3.9 million loss in the same period last year.
• Revenue decreased to $18.0 million from $19.3 million year-over-year, primarily due to lower sales in the JustCBD division and the impact of stop sale orders in Florida.
• Gross profit decreased to $3.9 million from $5.3 million year-over-year, with a gross margin of 21% compared to 28% in the prior year.
• Operating expenses decreased to $6.3 million from $7.7 million year-over-year, reflecting cost-cutting initiatives.
• The company recorded an asset impairment of $0.9 million related to operating lease right of use assets and property, plant and equipment at Vessel.
• The company's cash balance was $4.2 million as of March 31, 2024, and the company has an accumulated deficit of $145.6 million.
• The company's ability to continue as a going concern is dependent on its ability to obtain additional capital.

Sentiment

Score: 3

Explanation: The document highlights significant financial challenges, including decreased revenue, lower gross profit, asset impairments, and a going concern warning. While cost-cutting measures are noted, the overall tone is negative due to the company's precarious financial position and dependence on external funding.

Positives

• The net loss improved year-over-year, decreasing from $3.9 million to $3.4 million.
• Operating expenses decreased by $1.4 million year-over-year, indicating successful cost-cutting initiatives.
• The company completed the sale of its Colombian operations, allowing it to focus on core business divisions.
• The company has diversified cash flows across geographic and product lines.

Negatives

• Revenue decreased by $1.3 million year-over-year, primarily due to lower sales at JustCBD.
• Gross profit decreased by $1.5 million year-over-year, with a lower gross margin of 21%.
• The company recorded an asset impairment of $0.9 million related to Vessel.
• The company's cash balance is $4.2 million, and it has an accumulated deficit of $145.6 million.
• The company's ability to continue as a going concern is dependent on its ability to obtain additional capital.
• The company's JustCBD division was impacted by stop sale orders in Florida, resulting in a $0.7 million revenue loss.

Risks

• The company's ability to continue as a going concern is dependent on its ability to obtain additional capital.
• The company is facing challenges in realizing overhead reductions and achieving consistent profitability.
• The company's JustCBD division was impacted by stop sale orders in Florida, resulting in a $0.7 million revenue loss.
• The company is subject to various legal proceedings and claims.
• The company's growth is dependent on the expansion, regulation, and legalization of cannabis and cannabis derivative products.
• The company's ability to integrate acquired companies and extract synergies is a key determinant of its ability to expand organically.
• The company is subject to risks associated with product recalls and product viability.
• The company is subject to regulatory compliance risks and opposition to the cannabinoid industry.
• The company is subject to potential delisting resulting in reduced liquidity of its common shares.

Future Outlook

The company's ability to continue as a going concern is dependent on its ability to obtain additional capital. Management is evaluating various cost reductions and other alternatives and may seek to raise additional funds through the issuance of equity, debt securities, through arrangements with strategic partners, through obtaining credit from financial institutions or otherwise.

Management Comments

• Management has taken, and continues to implement, various cost-saving initiatives to lower overhead costs.
• Management believes that EBITDA and Adjusted EBITDA provide meaningful and useful financial information as these measures demonstrate the operating performance of the business.
• Management believes that the probable ultimate resolution of any such proceedings and claims, individually or in the aggregate, will not have a material adverse effect on the financial condition of the Company, taken as a whole as at March 31, 2024.

Industry Context

The company operates in the highly regulated cannabis industry, which is subject to evolving regulations and consumer sentiment. The company's performance is impacted by international cannabis developments, product evolution, and brand acceptance. The company is focused on the most robust markets in Germany and the European Union.

Comparison to Industry Standards

• The company's gross margin of 21% is lower than some of its peers in the cannabis industry, which can range from 30% to 60% depending on the product mix and market.
• The company's operating expenses as a percentage of revenue are higher than some of its more established competitors, indicating a need for further cost optimization.
• The company's reliance on external financing is a common challenge for many smaller cannabis companies, but the company's current cash position and accumulated deficit raise concerns about its long-term viability.
• The company's legal challenges are not uncommon in the cannabis industry, but the magnitude of the claims and the potential impact on the company's financial position are significant.
• The company's acquisition strategy is similar to other companies in the industry, but the company's ability to integrate these acquisitions and realize synergies is critical for its success.
• Compared to companies like Canopy Growth and Aurora Cannabis, Flora Growth is a smaller player with a more diversified product portfolio, including pharmaceutical distribution, which provides a different risk profile.

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in a legal dispute with a former shareholder of ACA Mueller, with a court order to pay $3.0 million plus interest.
• A group representing the sellers of Just Brands LLC brought an action against the Company claiming that the Company failed to promptly issue additional shares.
• The company is involved in legal proceedings with Maria Beatriz Fernandez Otero and Sara Cristina Jacome De Torres, and Ramon Ricardo Castellanos Saenz and Miriam Ortiz, regarding alleged consulting services.
• The company is involved in an action brought in the Ontario Superior Court of Justice by Nathan Shantz and Liberacion e Inversiones S.A. against various parties including Clifford Starke, the Company's current CEO and FGH's former Chief Executive Officer, and FGH.
• Just Brands and the Florida Department of Agriculture and Consumer Services agreed to a settlement, whereby Just Brands will remove the products subject to the stop sales orders from the state of Florida, pay the Department $60,500 to reimburse the Departments attorneys fees, and accept a five-year revocation of its food permit in the state of Florida.

Stakeholder Impact

• Shareholders are impacted by the company's financial challenges and the potential for dilution from future equity offerings.
• Employees may be impacted by cost-cutting measures and potential restructuring.
• Customers may be impacted by product recalls and changes in product availability.
• Suppliers may be impacted by the company's financial challenges and potential changes in purchasing patterns.
• Creditors may be impacted by the company's financial challenges and potential difficulties in meeting its obligations.

Next Steps

• The company will continue to implement cost-saving initiatives to lower overhead costs.
• The company will seek to raise additional funds through the issuance of equity, debt securities, through arrangements with strategic partners, through obtaining credit from financial institutions or otherwise.
• The company will take all necessary steps and make commercial best efforts to convene a shareholder meeting as soon as reasonably practicable to approve the Second Closing of the TruHC Holding GmbH acquisition.
• The company will continue to defend itself through appropriate legal proceedings.

Key Dates

Keywords

cannabis, CBD, pharmaceutical, distribution, JustCBD, Vessel, Phatebo, financial results, cost reduction, asset impairment, legal proceedings, going concern, capital raise